OncoSwift® Tumor of Unknown Origin Multi-Omics
Unique Identifier:
ML-S016
Name on Requisition:
OncoSwift® Tumor of Unknown Origin Multi-Omics
Product Line:
ST
Panel Group:
Solid Tumor Panels
Panel Name:
OncoSwift® Tumor of Unknown Origin Multi-Omics
Methodology
Molecular
NGS
Test Description and clinical significance
Genes
AKT1, ALK, AR, ARAF, BRAF, CD274, CDK4, CDKN2A, CHEK2, CNNB1, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, GNA11, GNAQ, GNAS, HRAS, IDH1, IDH2, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, PTEN, RAF1, RET, ROS1, SMO and TP53
Disease:
Tumor of Unknown Origin (TUO)
The OncoSwift® Tumor of Unknown Origin (TUO) Multi-Omics Panel integrates DNA mutation profiling, RNA fusion detection, and gene expression analysis to characterize tumors lacking a clear site of origin. This comprehensive assay provides molecular insights to aid in tumor classification, guide prognosis, and inform selection of targeted or immune-based therapies.
Specimen Requirements
Preparation:
FFPE tissue or slides
Collection:
In case of FFPE sections, 5-10 sections are recommended at 4 to 10 micron.
Stability:
Stored at room temperature
Unacceptable Conditions:
Specimen submitted is in the incorrect fixative. Insufficient specimen (less than 10% of tumor). Bacterial over growth. Submitted with incomplete requisition form (unless a requisition is subsequently sent). Unlabeled or improperly labeled specimens, without contact information or when failing to
reach the ordering physician for clarification. Decalcified specimens. Improperly stored DNA.
Storage & Transport
Store FFPE blocks and slides at room temperature. Slides may be stored at ambient
CPT(s)
81459
New York Approved
Yes
TAT
7
Requisition Type
ST
Levels of Service
Full
DexS Code
Z05CL
Prefix
MI
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
